【活動紀實】2025 Taiwan Real-World Evidence Symposium 圓滿落幕，OHDSI Taiwan Society 共同參與推動 RWE 發展對話
【活動紀實】2025 Taiwan Real-World Evidence Symposium 圓滿落幕，OHDSI Taiwan Society 共同參與推動 RWE 發展對話
由 Taiwan-Overseas Pharmacy Networking（TOPharmNet）主辦的 2025 Taiwan Real-World Evidence Symposium（TRWE 2025） 已於上週末圓滿落幕。此次為期三天的線上研討會匯聚來自產官學研界的多位專家，針對真實世界數據與證據（Real-World Data/Real-World Evidence, RWD/RWE）在醫療產業的應用進行深度探討。
OHDSI Taiwan Society 很榮幸作為協辦單位之一，共同參與推動本次活動。學會理事長 徐之昇教授（臺北醫學大學） 擔任論壇「真實世界證據在醫療產業中的機會與挑戰」之與談人，分享了台灣在政府政策支持、資料整合挑戰、隱私保護機制，以及人才培育等面向的實務觀察，並強調 OHDSI 架構下的 分散式分析模式（Federated Analysis）與去識別化技術（De-identification） 可有效兼顧研究效率與個資安全，是實現跨院、跨國合作的關鍵策略。
此外，本會學生成員 Phuc也於「Student Research Spotlight」中發表其利用 OMOP-CDM 架構 進行帕金森氏症與癌症流行病學研究之成果，展現年輕研究者在 RWE 領域的潛力與實作能力。
TRWE 2025 不僅是一場藥學界的交流盛會，也是一個跨世代、跨領域共同聚焦 RWE 發展策略的寶貴平台。OHDSI Taiwan Society 將持續推動台灣健康資料標準化、臨床應用研究與青年人才培育，歡迎更多對 RWD/RWE 有興趣的醫療與研究夥伴加入本會，一同推動台灣在全球數據科學生態中的角色！
📌 活動名稱｜2025 Taiwan Real-World Evidence Symposium
📅 活動時間｜2025年7月18日至20日（線上舉行）
🎤 協辦單位｜OHDSI Taiwan Society、TASPOR、University of Minnesota
🌐 主辦單位｜Taiwan-Overseas Pharmacy Networking（TOPharmNet）
Event Recap｜2025 Taiwan Real-World Evidence Symposium Successfully Concluded – OHDSI Taiwan Society Proud to Support RWE Dialogue
The 2025 Taiwan Real-World Evidence Symposium (TRWE 2025), organized by Taiwan-Overseas Pharmacy Networking (TOPharmNet), successfully concluded last weekend. This three-day virtual event brought together experts from academia, government, industry, and healthcare sectors to explore the applications and future of Real-World Data and Real-World Evidence (RWD/RWE) in healthcare.
OHDSI Taiwan Society was honored to serve as one of the co-organizers and to help facilitate this important initiative. Our Society President, Professor Jason Hsu (Taipei Medical University), participated as a panelist in the session “Opportunities and Challenges of RWE in the Healthcare Industry,” sharing insights on several key topics, including:
- The increasing support from the Taiwanese government for applying RWE in drug safety and public health policy
- The ongoing challenges of data integration across institutions and the need for standardization
- The role of Federated Analysis and De-identification techniques within the OHDSI framework in achieving both research efficiency and data privacy—crucial strategies for enabling scalable, cross-institutional and international collaboration
- The importance of simultaneously advancing methodological training and practical experience for next-generation RWE leaders
In addition, OHDSI Taiwan student member Phuc presented his research during the Student Research Spotlight session, showcasing his work on Parkinson’s disease and cancer epidemiology using the OMOP Common Data Model (CDM). His presentation demonstrated both the capability and promise of emerging researchers in the RWE field.
TRWE 2025 was more than just a pharmacy-focused exchange—it served as a valuable platform for cross-generational and cross-disciplinary collaboration toward shaping the future of RWE.
OHDSI Taiwan Society remains committed to advancing data standardization, real-world clinical research, and youth talent development in Taiwan. We welcome all healthcare and research professionals interested in RWD/RWE to join our community and work together in shaping Taiwan’s role in the global health data science ecosystem.
📌 Event Title｜2025 Taiwan Real-World Evidence Symposium
📅 Date｜July 18–20, 2025 (Virtual)
🎤 Co-organizers｜OHDSI Taiwan Society, TASPOR, University of Minnesota
🌐 Organizer｜Taiwan-Overseas Pharmacy Networking (TOPharmNet)
